Start Date
August 31, 1994
Study Completion Date
June 30, 2004
docetaxel
paclitaxel
Oncology-Hematology Associates, Philadelphia
George Washington University Medical Center, Washington D.C.
Carolinas Hematology-Oncology Associates, Charlotte
Greenville Hospital System, Greenville
Georgia Cancer Specialists - DeKalb, Decatur
Montclair Regional Cancer Center, Birmingham
Baptist Regional Cancer Center - Knoxville, Knoxville
James Graham Brown Cancer Center at University of Louisville, Louisville
Hematology Oncology Consultants Inc, Columbus
Cleveland Clinic Taussig Cancer Center, Cleveland
Rush-Presbyterian-St. Luke's Medical Center, Chicago
Mercy Arch Hematology Oncology, P.C., St Louis
University of Arkansas for Medical Sciences, Little Rock
Highlands Oncology Group, P.A. - Fayetteville, Fayetteville
Charles A. Sammons Cancer Center, Dallas
University of Colorado Cancer Center at University of Colorado Health Sciences Center, Denver
Green Cancer Center at Scripps Clinic, La Jolla
Sidney Kimmel Cancer Center, San Diego
Northeast Arkansas Clinic, Jonesboro
California Cancer Care, Inc., Greenbrae
Norwich Cancer Center, Norwich
Baptist Regional Cancer Institute - Jacksonville, Jacksonville
Maine Center for Cancer Medicine and Blood Disorders - Scarborough, Scarborough
Tufts - New England Medical Center, Boston
University of Michigan Comprehensive Cancer Center, Ann Arbor
Southfield Oncology Institute, Inc., Southfield
Blumenthal Cancer Center at Carolinas Medical Center, Charlotte
Charles M. Barrett Cancer Center at University Hospital, Cincinnati
Penn State Cancer Institute at Milton S. Hershey Medical Center, Hershey
Roger Williams Medical Center, Providence
University of Texas Health Science Center at San Antonio, San Antonio
Medical College of Wisconsin Cancer Center, Milwaukee
Lead Sponsor
Aventis Pharmaceuticals
INDUSTRY